HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xueyong Zheng Selected Research

DNA excision repair protein ERCC-5

1/2018High expression of ERCC5 predicts a poor prognosis in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xueyong Zheng Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
12/2020 - 01/2020
2Neoplasms (Cancer)
01/2020 - 01/2018
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2024
1Neoplasm Metastasis (Metastasis)
01/2024
1Carcinogenesis
01/2018

Drug/Important Bio-Agent (IBA)

1Histone Deacetylase 2IBA
01/2024
1CalciumIBA
01/2024
1Sorafenib (BAY 43-9006)FDA Link
12/2020
1Circular RNAIBA
12/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Androgen Receptors (Androgen Receptor)IBA
01/2020
1DNA excision repair protein ERCC-5IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2018

Therapy/Procedure

2Therapeutics
12/2020 - 01/2020